vanilmandelic acid has been researched along with Focal Neurologic Deficits in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, S | 1 |
| Carlsen, N | 1 |
| Glenting, P | 1 |
| Helweg-Larsen, J | 1 |
| Martin, ES | 1 |
| Griffith, JF | 1 |
2 other studies available for vanilmandelic acid and Focal Neurologic Deficits
| Article | Year |
|---|---|
Encephalopathia myoclonica infantilis (Kinsbourne) and neuroblastoma in children. A report of three cases.
Topics: Abdominal Neoplasms; Acute Disease; Ataxia; Catecholamines; Cerebellar Diseases; Child, Preschool; C | 1974 |
Myoclonic encephalopathy and neuroblastoma. Report of a case with apparent recovery.
Topics: Anticonvulsants; Cyclophosphamide; Female; Humans; Infant; Mediastinal Neoplasms; Myoclonus; Neurobl | 1971 |